Wanlin Dai

865 total citations · 2 hit papers
24 papers, 525 citations indexed

About

Wanlin Dai is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Wanlin Dai has authored 24 papers receiving a total of 525 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 6 papers in Surgery and 6 papers in Molecular Biology. Recurrent topics in Wanlin Dai's work include Gallbladder and Bile Duct Disorders (5 papers), Pediatric Hepatobiliary Diseases and Treatments (4 papers) and Drug Transport and Resistance Mechanisms (4 papers). Wanlin Dai is often cited by papers focused on Gallbladder and Bile Duct Disorders (5 papers), Pediatric Hepatobiliary Diseases and Treatments (4 papers) and Drug Transport and Resistance Mechanisms (4 papers). Wanlin Dai collaborates with scholars based in China, United Kingdom and United States. Wanlin Dai's co-authors include Shuodong Wu, Dianbo Yao, Chaoliu Dai, Ming Dong, Liwei Pang, Jing Kong, Jing Kong, Xiao Xue, Yuting Zheng and Yuanyuan Fang and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Endocrinology and Carcinogenesis.

In The Last Decade

Wanlin Dai

23 papers receiving 521 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

MUC2 and related bacterial factors: Therapeutic targets for ulcerative colitis

2021 171 citations Dianbo Yao, Wanlin Dai et al. EBioMedicine profile →
Epigenetics-targeted drugs: current paradigms and future challenges

2024 94 citations Wanlin Dai, Xinbo Qiao et al. Signal Transduction and Targeted Therapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wanlin Dai China	12	246	83	76	62	61	24	525
Yanfang Wu China	13	229 0.9×	54 0.7×	60 0.8×	37 0.6×	65 1.1×	39	478
Sudipta Chakrabarti India	14	185 0.8×	97 1.2×	36 0.5×	54 0.9×	88 1.4×	80	726
Chengfei Wu China	11	287 1.2×	143 1.7×	75 1.0×	44 0.7×	53 0.9×	14	515
Wei‐Ye Liu China	7	324 1.3×	55 0.7×	78 1.0×	28 0.5×	63 1.0×	10	677
Daniel Okin United States	8	203 0.8×	62 0.7×	38 0.5×	54 0.9×	59 1.0×	15	551
Xiang Tan China	19	402 1.6×	143 1.7×	100 1.3×	49 0.8×	84 1.4×	57	880
Xiaoshuang Liu China	17	254 1.0×	88 1.1×	86 1.1×	53 0.9×	71 1.2×	55	755
Liang Luo China	14	286 1.2×	102 1.2×	35 0.5×	95 1.5×	106 1.7×	33	608
Hui-Hui Sun China	11	274 1.1×	126 1.5×	45 0.6×	85 1.4×	113 1.9×	24	616
Yiwen Li China	19	363 1.5×	65 0.8×	40 0.5×	40 0.6×	148 2.4×	47	920

Countries citing papers authored by Wanlin Dai

Since Specialization

Citations

This map shows the geographic impact of Wanlin Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wanlin Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wanlin Dai more than expected).

Fields of papers citing papers by Wanlin Dai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wanlin Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wanlin Dai. The network helps show where Wanlin Dai may publish in the future.

Co-authorship network of co-authors of Wanlin Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Wanlin Dai. A scholar is included among the top collaborators of Wanlin Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wanlin Dai. Wanlin Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yang, Shaojie, Wanlin Dai, Yang Sun, et al.. (2025). Role of plasma metabolome in mediating the effect of plasma lipidome on NAFLD: a Mendelian randomization study. Frontiers in Endocrinology. 15. 1436827–1436827.

Dai, Wanlin, Xinbo Qiao, Yuanyuan Fang, et al.. (2024). Epigenetics-targeted drugs: current paradigms and future challenges. Signal Transduction and Targeted Therapy. 9(1). 332–332. 94 indexed citations breakdown →

Dai, Wanlin, Xiaolin Zhang, Yuting Zheng, et al.. (2023). Causal association between serum total bilirubin and cholelithiasis: a bidirectional two-sample Mendelian randomization study. Frontiers in Endocrinology. 14. 1178486–1178486. 3 indexed citations

Zhang, Chenghao, et al.. (2023). Resistance to Cholesterol Gallstone Disease: Hepatic Cholesterol Metabolism. The Journal of Clinical Endocrinology & Metabolism. 109(4). 912–923. 10 indexed citations

Liu, Yingyu, Wanlin Dai, Liwei Pang, et al.. (2023). Effectiveness and safety of central pancreatectomy in benign or low-grade malignant pancreatic body lesions: a systematic review and meta-analysis. International Journal of Surgery. Publish Ahead of Print(7). 2025–2036. 7 indexed citations

Zheng, Yuting, Shaojie Yang, Wanlin Dai, et al.. (2023). CHMP3 promotes the progression of hepatocellular carcinoma by inhibiting caspase‑1‑dependent pyroptosis. International Journal of Oncology. 64(1). 10 indexed citations

Dai, Wanlin, Liwei Pang, Xiaolin Zhang, et al.. (2022). Laparoscopic surgery for gallstones or common bile duct stones: A stably safe and feasible surgical strategy for patients with a history of upper abdominal surgery. Frontiers in Surgery. 9. 991684–991684. 2 indexed citations

Dai, Wanlin, et al.. (2022). Influence of adipose tissue immune dysfunction on childhood obesity. Cytokine & Growth Factor Reviews. 65. 27–38. 7 indexed citations

Dai, Wanlin, Jingnan Wang, Xiaolin Zhang, et al.. (2022). Osthole: An up-to-date review of its anticancer potential and mechanisms of action. Frontiers in Pharmacology. 13. 945627–945627. 24 indexed citations

10.

Pang, Liwei, et al.. (2021). Advances in the Study of Acute Acalculous Cholecystitis: A Comprehensive Review. Digestive Diseases. 40(4). 468–478. 26 indexed citations

11.

Pang, Liwei, et al.. (2021). Regulatory mechanisms of the bile salt export pump (BSEP/ABCB11) and its role in related diseases. Clinics and Research in Hepatology and Gastroenterology. 45(6). 101641–101641. 24 indexed citations

12.

Pang, Liwei, et al.. (2021). Diagnosis and Treatment of Male Accessory Breast Cancer: A Comprehensive Systematic Review. Frontiers in Oncology. 11. 6 indexed citations

13.

Dai, Wanlin, et al.. (2021). Th17 Cells in Depression: Are They Crucial for the Antidepressant Effect of Ketamine?. Frontiers in Pharmacology. 12. 649144–649144. 26 indexed citations

14.

Li, Qi, et al.. (2021). Cholecystectomy as a risk factor for metabolic dysfunction-associated fatty liver disease: unveiling the metabolic and chronobiologic clues behind the bile acid enterohepatic circulation. Journal of Physiology and Biochemistry. 77(4). 497–510. 11 indexed citations

15.

Yang, Shaojie, Liwei Pang, Wanlin Dai, et al.. (2021). Role of Forkhead Box O Proteins in Hepatocellular Carcinoma Biology and Progression (Review). Frontiers in Oncology. 11. 667730–667730. 29 indexed citations

16.

Yao, Dianbo, Wanlin Dai, Ming Dong, Chaoliu Dai, & Shuodong Wu. (2021). MUC2 and related bacterial factors: Therapeutic targets for ulcerative colitis. EBioMedicine. 74. 103751–103751. 171 indexed citations breakdown →

17.

Pang, Liwei, Shaojie Yang, Wanlin Dai, Shuodong Wu, & Jing Kong. (2021). Role of caveolin-1 in human organ function and disease: friend or foe?. Carcinogenesis. 43(1). 2–11. 13 indexed citations

18.

Wu, Shuodong, Wanlin Dai, Liwei Pang, et al.. (2021). Tetramethylpyrazine: A Review of Its Antitumor Potential and Mechanisms. Frontiers in Pharmacology. 12. 764331–764331. 19 indexed citations

19.

Pang, Liwei, et al.. (2020). Dilemma of the differential diagnosis of hilar cholangiocarcinoma and benign diseases: a single-center retrospective study. Carcinogenesis. 42(3). 442–447. 1 indexed citations

20.

Chen, Yongsheng, Shuodong Wu, Qi Li, et al.. (2020). Altered absorptive function in the gall bladder during cholesterol gallstone formation is associated with abnormal NHE3 complex formation. Journal of Physiology and Biochemistry. 76(3). 427–435. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact